Professional Documents
Culture Documents
By J.naresh M.pharm (Chemistry)
By J.naresh M.pharm (Chemistry)
By J.naresh M.pharm (Chemistry)
j.naresh
m.pharm (chemistry)
Introduction:
•Combinatorial Chemistry is a new method developed by academics
and researchers to reduce the time and cost of producing effective,
marketable and competitive new drugs.
•This technique uses the same reaction conditions with the same
reaction vessels to produce a large range of analogues.
• natural products
• synthetic custom crafted organic molecules made in
small numbers
• analogues of known actives (analogue me-toos)
Advantages
• Specific reactants can be bound to specific beads
• Beads can be mixed and reacted in the same reaction vessel
• Products formed are distinctive for each bead and physically distinct
• Excess reagents can be used to drive reactions to completion
• Excess reagents and by products are easily removed
• Reaction intermediates are attached to bead and do not need to be isolated
and purified
• Individual beads can be separated to isolate individual products
• Polymeric support can be regenerated and re-used after cleaving the
product
• Automation is possible
1. SOLID PHASE TECHNIQUES
Requirements
• A resin bead or a functionalised surface to act as a solid support
• An anchor or linker
• A bond linking the substrate to the linker. The bond must be
stable to the reaction conditions used in the synthesis
• A means of cleaving the product from the linker at the end
• Protecting groups for functional groups not involved in the
synthesis
1. SOLID PHASE TECHNIQUES
For amines.
Boc ( t-butoxycarbonyl )
Fmoc (9-fluorenylmetoxy carbonyl)
Tmsec (2 [ trimethylsilyl ] ethoxycarbonyl)
Linker R H
HO2C NHBoc
O O
R2 H
O O O
NH2 coupling NH NHBoc
R H R H H
R2
O HF
O
Release from OH
aa1aa2aa3 aan NH 2
solid support
HO2C aa1aa2aa3 aan NH2
Peptide
2. Parallel Synthesis
Aims:
• To use a standard synthetic route to produce a range of analogues,
with a different analogue in each reaction vessel, tube or well
Wells
ETC
2. Parallel Synthesis
Automated parallel synthesis of all 27 tripeptides from 3
amino acids
27 TRIPEPTIDES
27 VIALS
2. Parallel Synthesis
2.2 Automated parallel synthesis
Split
Ala Gly Ala Ala Ala Phe Ala Val Ala Ser
Phe Gly Phe Ala Phe Phe Phe Val Phe Ser
Val Gly Val Ala Val Phe Val Val Val Ser
Ser Gly Ser Ala Ser Phe Ser Val Ser Ser
Gly Gly Gly Ala Gly Phe Gly Val Gly Ser
3. Mixed Combinatorial Synthesis
The Mix and Split Method
Synthesis of all possible tri peptides using 3 amino acids
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
MIX
3. Mixed Combinatorial Synthesis
The Mix and Split Method
SPLIT
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
MIX
3. Mixed Combinatorial Synthesis
The Mix and Split Method
SPLIT
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
3. Mixed Combinatorial Synthesis
The Mix and Split Method
No. of 9 9 9
Tripeptides
3. Mixed Combinatorial Synthesis
The Mix and Split Method
No. of 9 9 9
Tripeptides
27 Tripeptides
3 Vials
3. Mixed Combinatorial Synthesis
The Mix and Split Method
Example:
Consider all 27 tripeptides synthesised by the mix and split strategy
from glycine, alanine and valine
Gly
Gly
Ala
Ala
Val
Val
Active
H2N H
O NH2 HN
MeOS O
NH H
O Tryptophan
SOMe
HN
Lysine
NH2
NH2
5.2 Tagging
Example NH2
NH2 NH2
RCHBrCO2H amino acid(aa 1) aa1
NH2 HN R'NH2
NH R
Step 1 Tag 1 NH R
Step 2
O Br
O Br
NH2 NH2
NH2 aa2 aa2
aa3 NH2
aa2
Tag 3 NH R
O NR'COR"
6. Identification of structures LIGHT from
combinatorial synthesis LIGHT
Deprotection CO2H
NHX NH2 NH2 NHX NHX NHX NHX NHX NHX NHX
coupling
NHX NHX NHX NHX NHX NHX NHX NHX NHX NHX NHX NHX
6. Identification of structures from
combinatorial synthesis
6.2 Photolithography - example Y
Y Y Y
repeat
O O Me
Y fluorescent tag
O 2N OMe
Target receptor
amino acids X= Nitroveratryloxycarbonyl
7. Planning a Combinatorial Synthesis
7.1 Aims
• To generate a large number of compounds
• To generate a diverse range of compounds
• Increase chances of finding a lead compound to fit a binding site
• Synthesis based on producing a molecular core or scaffold with
functionality attached
Centroid
or scaffold
Substituent
'arms' Binding groups
7. Planning a Combinatorial Syntheses
7.1 Aims
Target molecules should obey Lipinski’s ‘Rule of Five’ for oral
activity
Screen compound
library
RECEPTOR
BINDING
SITE
Privileged scaffolds
- scaffolds which are common in medicinal chemistry and
which are associated with a diverse range of activities
- benzodiazepines, hydantoins, benzenesulphonamide etc
7. Planning a Combinatorial Syntheses
7.2 Scaffolds - examples
R"
R O Me O
R4
N
O R2 R3 HO2C
N R1 R4
R' R2
O
N
N N N
X Ar R1 R2 O R5 R3
R3 R
R3 R4
O
R5
• Good scaffolds
•
C N
R1 O C N
R6
Spider like
O
• Low molecular weight
R2 • Variety of synthetic routes available
Dipeptides
7. Planning a Combinatorial Syntheses
7.2 Scaffolds - poor examples
OR5
Spider like and small molecular weight - good
R4O
R3O
O
OR1
points
OR2 But multiple OH groups
Glucose Difficult to vary R1-R5 independently
Me
Me
M.Wt. relatively high
Restricts no. of functional groups to keep MWt.<
R1CO 500
R2
Relatively few positions where substituents
Steroid easily added
O
R3
Tadpole like scaffold
Restricted region of
H 2N
R2
N
R
variability
Indole
References:
An introduction to Medicinal chemistry,3rd edition,
Graham L.Patric
web.centre.edu/muzyka/articles/ch14slides.ppt
www.authorstream.com/.../hariteja43-1369711-2003-
combinatorial-chemistry.
www.slideshare.net/.../combinatorial-chemistry-
hts-and-its-applications.